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Summary
It is well known that older people are more susceptible to morbid-
ity and mortality from infectious diseases, particularly from pul-
monary diseases such as pneumococcal pneumonia where
vaccines do not provide efﬁcient protection as in younger popula-
tions. We have previously shown that the B-cell repertoire in the
old is reduced and hypothesise that this may contribute to the
impaired humoral responses of the elderly. Here, we investigated
the repertoire and antibody responses to winter vaccination in
two age groups, aged 18–49 and 65–89. We found that the serum
IgM and IgA pneumococcal responses were signiﬁcantly impaired
in the older group, with no difference in IgG levels. IGHM spectra-
type analysis seems to be the most promising in terms of its pre-
dictive ability for vaccine responses. Spectratypes showed a clear
change in the repertoire at day 7 after vaccination, with a return
to the baseline levels at day 28. The changes at day 7 reﬂected
expansion of IGH sequences that have smaller, more hydrophilic,
CDR3 regions, and these changes were attenuated in the older
group. The older group was more likely to have spectratypes
indicative of a reduced diversity at day 0 and day 28. On average,
the baseline repertoire in the older group was comprised of larger
CDR3 regions than in the younger group. In conclusion, IgA and
IgM responses are signiﬁcantly impaired in the elderly pneumo-
coccal response and are likely key mediators of protection. Hydro-
philicity and⁄or small size of the IGH CDR3 appear to be important
in these responses.
Key words: ageing; B-cell repertoire; immunoglobulin A;
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Introduction
Streptococcus pneumoniae causes signiﬁcant morbidity and mortality in
young children and in older adults, and it is the most signiﬁcant secondary
infection associated with inﬂuenza. Many deaths attributed to inﬂuenza
may actually be caused by secondary pneumococcal infection (van der
Sluijs et al., 2004). Vaccination against pneumonia has proven difﬁcult in
these high-risk groups, where the standard 23-valent pneumococcal
polysaccharide (PPS) vaccine has not been as effective as in healthy young
adults (Moberley et al., 2008). Conjugate protein–PPS vaccines have had
more success in the very young but do not seem to improve vaccination
responses in the old (Baxendale et al., 2010). The overall picture of anti-
body responses in old age seems to be one of changes in speciﬁcity and
quality rather than a decrease in quantity (Howard et al., 2006). While
the efﬁcacy of vaccination against both inﬂuenza and pneumonia
decreases signiﬁcantly with age, the levels of poly-speciﬁc and autoreac-
tive antibodies increase with age. It has been reported that vaccine chal-
lenge in the older population can actually increase levels of anti-DNA
autoantibodies, implying an age-related loss of focus in the immune
response (Huang et al., 1992). A lack of focus in afﬁnity maturation of
antibodies has been implied by the fact that the B cells in germinal centre
responses in Peyer’s patches of older people appear to be under less
selection pressure than in younger samples, although this may be a tis-
sue-speciﬁc phenomenon (Banerjee et al., 2002).
Speciﬁc IgG antibody levels are sometimes used as a correlate of pro-
tection in assessing vaccine responses, although this may not always be
the best measure. It has been shown for PPS IgG responses that the actual
levels of PPS-speciﬁc IgG do not always correlate with the functional
opsonophagocytic assay (Anttila et al., 1999). While IgG is by far the
most abundant antibody produced in vaccine responses in general, we do
not believe it is always the most relevant. When considering the most
common site of infection by pneumococcus, natural immunity against
colonisation and pneumonia is most likely provided by antibodies of IgA
and IgM isotype which are generated within the mucosal-associated lym-
phoid tissue. In the case of the PPS vaccine, the antigen is polysaccharide,
a type II T-cell-independent (TI2) antigen. TI2 responses differ from
T-dependent (TD) responses in many respects, and it has been suggested
that these two responses might be differentially affected with ageing
(Frasca et al., 2007). IgM memory B cells have been shown to be impor-
tant in providing early defence against pneumococcal infection, and the
loss of IgM-producing B cells has been shown to impair the potential to
generate adaptive immune responses (Boes et al., 1998; Kruetzmann
et al., 2003). Postvaccine IgM antibodies with characteristics of natural
antibodies can be protective against invasive pneumococcal disease
(Baxendale et al., 2008). Although some reports do not ﬁnd a change in
levels of IgM memory cells with age (Colonna-Romano et al., 2006), oth-
ers have shown an age-related decrease in IgM memory cells with age
and indicated that induction of IgM responses in the elderly might be
impaired (Shi et al., 2005). The best evidence for a key role of IgM in
pneumococcal protection is a recent report that depletion of IgM anti-
bodies from the serum severely reduces opsonophagocytic activity
against two common PPS serotypes (Park & Nahm, 2011). IgM is extre-
mely efﬁcient at opsonisation compared with IgG; therefore, even a small
age-related change in IgM levels may be signiﬁcant for efﬁcacy of vac-
cines in old age.
Antibody genes can be used to measure the diversity of different B-cell
populations, and there have been some reports that gene usage against
speciﬁcPPSserotypesmayvary withage(Kolibabet al., 2005).Thesedata
are not directly relevant to a study of IgM and IgA PPS responses, because
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lthey are limited to only two of the six IGHV gene families of the IgG iso-
type against two PPS serotypes. However, they do indicate that an
immune failure to respond to PPS antigens may have origins in an altered
B-cell repertoire. Immunoglobulin heavy chain sequences are comprised
of three different genes (IGHV, IGHD and IGHJ) in conjunction with a con-
stant region, of either alpha, gamma, mu or epsilon, that determines the
class of antibody produced. The IGHV–IGHD–IGHJ junctional region of
thegeneis knownas theCDR3regionandishighlydiverse.It is thisregion
that is thought to be most important in the antigen-binding pocket of the
antibody (Kirkham & Schroeder, 1994). The diversity is such that in a nor-
mal population of B cells, there will be a Gaussian distribution of CDR3
sizes, which can be visualised by separation of fragments electrophoreti-
cally to produce a spectratype. Departure from a Gaussian distribution is
taken to indicate perturbation of a repertoire by clonal expansion of cells
of a particular CDR3 size. Although B-cell spectratypes have previously
been used to measure perturbations in diversity of repertoire through old
age (Gibson et al., 2009), or through disease (Foreman et al., 2008),
there has been no systematic spectratype study to determine how the
repertoireof different peripheral bloodB cells changes after vaccination.
We have previously shown that a DNA spectratype can show a reduced
diversity of B-cell repertoire in older people and that this is correlated with
frailty (Gibson et al., 2009). It is thought that a reduced diversity is a con-
sequence of a decreased naı ¨ve B-cell input from the bone marrow and
therefore, within the homeostatic B-cell environment, a lack of contrac-
tion of antigen-experienced B-cell expansions to maintain the overall
B-cell number in the periphery (Cancro et al., 2009). We hypothesised
that a reduced B-cell diversity in the ﬁrst instance might be the cause of a
reduced immune response to challenge in older people, there being less
novel naı ¨ve cells to respond to challenge. To test this hypothesis, we
investigated the effect of vaccination on PPS-speciﬁc serum IgM, IgA, as
well as IgG antibodies, and on cDNA-derived spectratypes for the corre-
sponding IGHM, IGHA and IGHG classes.
Results
Spectratype analysis shows challenge-related changes
To determine whether we could detect vaccination-related changes in
B-cell repertoire, we used primers speciﬁc for IGHM, IGHA and IGHG clas-
ses, together with an IGHV framework 3-speciﬁc primer, to amplify the
CDR3 region of Ig genes in an isotype-speciﬁc manner. Samples were of
cDNA from peripheral blood lymphocytes at day 0, immediately before
vaccination, and at days 7 and 28 after vaccination. The resulting frag-
ments were separated by high-resolution electrophoresis to produce
spectratypes, and after normalising all the samples, the mean and stan-
dard deviation (SD) values were used to determine the underlying Gauss-
ian distribution for each spectratype (Fig. 1a).
At day 0, the IGHM spectratypes were generally a better ﬁt to a Gauss-
ian distribution than IGHA spectratypes and the samples in the young
group were a better ﬁt than in the old group (Fig. 1b). As expected, there
is interindividual variability in spectratypes, and this is especially pro-
nounced in IGHA and IGHG, presumably due to the fact that switched
samples reﬂect prior antigen experience and will therefore contain
expanded populations of cells that reﬂect the individual’s prior exposure.
However, even in the day 0 IGHM samples that closely approximate
Gaussian distributions, there are interindividual differences in repertoire
evidenced by differences in mean, SD, skewness and kurtosis (Fig. 1c). As
the IGHM spectratype reﬂects a population of cells where the majority
(approximately 85%) are naı ¨ve cells, then this implies that the baseline
naı ¨ve B-cell repertoire varies on an individual basis.
In both young and old samples, there is a striking change in the reper-
toire at day 7 after challenge with vaccine. The spectratypes change at
day 7 in all three isotypes and return to shapes more similar to the day 0
baseline for that individual by day 28. This is seen more easily in the
smoother spectratypes of IGHM than in those of the more variable IGHA
and IGHG isotypes (Fig. 1a). In particular, the pre-existing clonal expan-
sions of IgG meant that the background noise in the data prevented the
detection of vaccine or age-induced changes of IgG spectratypes at this
sample size. As a perturbed B-cell repertoire can be changed in several
respects, with increases or decreases in peaks at different points across
the spectratype for each individual, then the overall postchallenge
changes in spectratypes are best illustrated by measurements of the cor-
relation of the sample spectratype to the baseline Gaussian distribution
(CGD), as seen in Fig. 1d. The CGD decreases at day 7 and returns to the
higher value at day 28. Although the marked variability in IGHG values
masks any differences that might exist between day 0 and 7 in either age
group, there was a signiﬁcant change between day 0 and 7 in the IGHM
and IGHA spectratypes in both age groups.
Evidence in support of the notion that changes in response to antigen
challenge are inﬂuenced by particular characteristics of the Ig genes
involved is shown by highly signiﬁcant changes in the mean values of the
spectratypes, which reveal evidence for strong selective pressure in favour
of a smaller CDR3 region in the responding population (Fig. 1e). Both
groups showed a signiﬁcant decrease in mean CDR3 length between day
0 and 7 in IGHM and IGHA spectratypes. Most notable is the fact that the
old group has longer CDR3 regions than the young group, with signiﬁ-
cantly higher mean CDR3 values for IGHM genes at all three time points,
indicating that the older people have longer CDR3 lengths even at base-
line in the absence of challenge.
Sequence analysis indicates a change in the underlying
repertoire as well as expanded B-cell populations
To conﬁrm the hypothesis that the spiky characteristics (low CGD values)
of the day 7 cDNA-based spectratypes reﬂect a clonal expansion of anti-
gen-speciﬁc B cells, we used high-throughput sequencing to obtain
36 935 immunoglobulin sequences from PBMC samples at days 0, 7 and
28 from six old (aged 70–89) and six young (aged 19–45) individuals.
Sequences that belonged to the same clone family were identiﬁed by
shared CDR3 regions (Table 1). Figure 2 clearly shows that although
there is considerable interindividual variability, clonal expansions occur at
day 7 and to a greater extent in switched isotypes than in IGHM. There is
still some evidence of clonality at day 0 and 28, even in the IGHM popula-
tions. The older group in particular contained some individuals with con-
siderable clonality of switched sequences at days 0 and 28, indicating a
lack of diversity even in the absence of immediate antigen challenge.
Sequence data can be displayed to produce ‘virtual spectratypes’.
These have the advantage of being able to visualise the distinction
between an underlying repertoire perturbation and a change because of
clonal expansion of B cells. The CDR3 sizes of all sequences were counted,
and the frequency distribution was plotted to give a virtual spectratype of
all sequences (Fig. 3a). In agreement with the data from the polymerase
chain reaction (PCR) spectratypes described earlier, in the young group,
there is a substantial shift towards a smaller CDR3 size at day 7 after chal-
lenge, while days 0 and 28 are generally similar to each other (Fig. 3a,b).
The day 28 values for IgM appear to reach a higher CDR3 length than day
0, which are not in agreement with the data from the spectratypes in
Fig. 1. As the sequence data are obtained from only six subjects per
group, these are more affected by interindividual variation than the spec-
tratype data. It is possible that one of the six subjects had an inﬂux of
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923IgM-containing B cells with longer CDR3s (such as transitional B cells, as
reported by Wu et al., 2010) that could have caused this discrepancy. The
old group has a more subtle shift at day 7, and there is a signiﬁcant differ-
ence in CDR3 size between young and old in IGHM at all time points, and
in IGHA at day 7 (Fig. 3b). To explore whether clonal expansion was a
dominant effect accounting for the age- and time-related differences,
these virtual spectratypes were plotted using unique Ig gene sequences
(clonotypes), to remove the effect of clonal expansion. Young and old
had an equivalent response in terms of the change in CDR3 size at day 7
postimmunisation (Fig. S1). However, the age-related differences
between overall CDR3 size values remained signiﬁcant (Fig. 3c).
We investigated whether clonal expansions in the different age groups
occurred in particular sequences by determination of clone sizes at the
different CDR3 sizes for both young and old groups. Larger clone sizes
correlate with lower CDR3 sizes in the young group only (Fig. S2). Analy-
sis of the unique sequences from the younger group revealed a signiﬁcant
positive correlation between CDR3 size and hydrophobicity (r
2 = 0.017,
P < 0.0001, Fig. S3). We also saw a signiﬁcant decrease in hydrophobic-
ity in expanded clones when compared with single sequences in the
below average CDR3 size range (Fig. 3d). This selection for decreased
hydrophobicity in responding clones was not because of any one particu-
lar CDR3 size (Fig. 3e).
Serology
The serum response to immunisation was characterised by pneumococcal
PS-speciﬁc ELISA. To facilitate comparison of C-PS antibody responses with
multiple metrics, we used a pooled ELISA incorporating seven key sero-
types (4, 6B, 9, 14, 18C, 19F and 23F). IgG was detected at higher concen-
tration than IgA or IgM, and the older cohort had higher concentrations of
IgG pre-immunisation relative to younger adults, although this difference
was not signiﬁcant (Fig. 4a). A rise in serum IgG, IgA and IgM was seen in
all individuals postimmunisation; however, the time course was different
by isotype and varied between the two cohorts. IgG serum responses were
similar between young and old, peaking at day 28, consistent with data
from other groups (Lee et al., 2010; Park & Nahm, 2011). In contrast, in
the young individuals, an early peak IgA serum response was detected at
day 7, while in the older cohort, the rise in IgA was more gradual, peaking
at day 28 (Fig. 4b). The serum IgM response to immunisation was reduced
in the older cohort at days 7 and 28 postimmunisation (Fig. 4c).
(a) (b)
(c)
(d) (e)
Fig. 1 B-cell CDR3 spectratypes show individual variability and show challenge-related changes. (a) Spectratypes of samples from one individual before, and at 7 and 28 days
after, receiving winter vaccination for inﬂuenza and pneumonia, showing CDR3 size distribution histograms for the IGHM, IGHA and IGHG immunoglobulin genes in
peripheral blood B cells. The best ﬁt Gaussian distribution curve for each sample, as determined based on the mean and SD values, is overlaid. The X-axis represents the CDR3
size in nucleotides, and the Y-axis is the proportion of the CDR3 sequences at each size. (b) Spectratype data show that diversity of repertoire decreases with age and with
change from IGHM to switched isotypes on day 0 before challenge. High correlation to the underlying Gaussian distribution (CGD) is an indicator of a high level of diversity in
the population. The Y-axis shows the per cent of spectratypes that have a correlation value of over 0.9 in each group. Variables were compared using chi-squared test with
Bonferroni post-test, and signiﬁcant values for comparisons between isotypes are indicated using * and between ages are indicated by †. (c) CDR3 spectratypes can follow a
Gaussian distribution but may still differ between individuals. Examples of IGHM spectratypes from three different young individuals before vaccination are shown, with
differing mean, SD, skew, kurtosis and CGD values. (d) Challenge and age-related changes in repertoire diversity as indicated by the spectratype correlation to the baseline
CGD in the young and old age groups of different isotypes before, and at 7 and 28 days after vaccination. Groups were compared using Mann–Whitney u-test. (e) Challenge
and age-related changes of the mean CDR3 length. Groups were compared using Mann–Whitney u-test. Error bars are SEM, *P < 0.01, **P < 0.001 and ***P < 0.0001.
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924As it has been reported that levels of autoantibodies can also increase
as a result of vaccine challenge (Huang et al., 1992), we measured the
levels of IgG antinuclear antibodies (IgG ANA) before and after vaccina-
tion using a HEp2 slide-based cytometric assay (Hiemann et al., 2007,
2009). It can be seen from Fig. 4d that as expected, there is an age-
related difference in the levels of IgG ANA; however, this is unchanged by
vaccine challenge. Curiously, we saw a signiﬁcant correlation between
longer CDR3 size and autoantibody IgG ANA at day 0 (Fig. 4e). This may
be an indirect relationship, because both values correlate with age,
although there was still a signiﬁcant correlation when only the over 65s
are considered (r
2 = 0.2045, P = 0.0303).
Ig repertoire correlates with antibody response
Given that there were signiﬁcant age- and challenge-related changes in
the metrics associated with the B-cell spectratypes, we hypothesised that
there would be a relationship between the serum antibody response and
spectratype data.
Leptokurtosis (higher peakedness) was signiﬁcantly correlated with
higher PPS-speciﬁc serum IgA values but did not quite reach signiﬁcance
when compared with IgM values (Fig. S4a,c). Small SD values of spectra-
types at day 7 were correlated with both higher PPS-speciﬁc serum IgM
and IgA values (Fig. S4b,d). As the predictive value of spectratypes would
be of much more value if we could predict the vaccine response prior to
administering the vaccine, we looked for correlations between the peak
PPS-speciﬁc IgA and IgM responses and the spectratype metrics at day 0.
Despite the fact that the mean CDR3 size values of the IGHM spectra-
types had shown signiﬁcant age-related differences, correlations
between the IGHM day 0 values and serum IgA, IgG and IgM levels did
not reach signiﬁcance (Fig. S5).
We hypothesised that a less diverse repertoire would predict a worse
immune response and therefore looked to see whether CGD at day 0 can
predict the peak antibody response. There did not appear to be any sim-
ple correlative relationship between spectratype metrics and serology for
the IgA and IgG responses, although there were indications that the spec-
tratypes and antibody responses were related. In IGHM in particular, the
best PPS-speciﬁc IgM antibody responses at day 28 were indeed associ-
ated with a CGD value nearer to 1 (i.e. a more diverse repertoire), with a
value below 0.8 predictive of a poor antibody response (Fig. 5,
r
2 = 0.06574, P = 0.037). However, having a CGD value > 0.8 does not
guarantee a good IgM antibody response at any age. It could be seen that
the younger group was more tolerant of a loss of diversity. A day 0 IGHM
spectratype CGD value of lower than 0.9, together with age over 65, indi-
cated a worse IgM response.
Discussion
We observed that even in the absence of challenge, there are differences
in the B-cell spectratypes between individuals (Fig. 1). These can repre-
sent changes in B-cell repertoire because of prior antigen exposure or
changes in the naı ¨ve repertoire. With regard to the latter, the IGHM spec-
tratypes are particularly interesting, because the assumption is that they
largely represent naı ¨ve B cells. This would imply that there is an element
of interindividual variation in factors affecting repertoire generation in
central B-cell development. These could be factors related to gene rear-
rangement, such as preferential use of different IGH genes or terminal
deoxynucleotidyl activity. Alternatively, they could be factors associated
with tolerance selection of the repertoire such as occurs in the bone mar-
row and in the transitional B-cell stages (Wardemann et al., 2003). These
factors may also be responsible for the age-related differences in IGHM
CDR3 size that we see before vaccine challenge.
Vaccine challenge results in cellular changes in the peripheral blood at
day 7 (Wrammert et al., 2008; Baxendale et al., 2010). These can be
detected both by spectratype metrics showing a decreased diversity
(a)
(b)
Fig. 2 Challenge-induced B-cell clonality changes. Clonality was determined by
dividing the overall number of sequences by the number of different clonotypes
(deﬁned by CDR3 region identity). Data represent day 0, 7 and 28 for (a) six young
samples (b) and six old samples. Data are plotted separately to indicate
interindividual variation, as indicated by different bar shading.
Table 1 The numbers of immunoglobulin CDR3 sequences from each individual
Groups Donor ID
Age
(years)
No. of all sequences
No. of unique
clonotypes*
IgA and IgG IgM IgA and IgG IgM
Young 34 22 4704 978 1505 758
39 19 1454 608 953 490
53 22 2335 1011 1075 752
62 33 946 39 471 31
63 22 5157 689 1853 448
69 45 1026 388 398 175
Old 4 71 5201 558 1588 426
6 76 901 845 442 567
7 87 1610 92 727 57
14 70 3823 550 1052 329
27 89 1035 53 454 42
42 73 2519 413 885 343
Total – 30711 6224 11403 4418
*Sequences were grouped into clone families by similarity of DNA sequence, and
one example clonotype from each family was counted. As different primers were
used to isolate the different isotypes, the relative numbers of IgM ⁄ IgG ⁄ IgA
sequences cannot be taken to reﬂect the relative numbers occurring in vivo.
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925(lower CGD value of spectratype) and by sequence analysis indicating an
increase in clonality. Although the sequence analysis only compared six
old and six young, and there was interindividual variability (Fig. 2), we
could still show a decrease in the extent of clonal expansion at day 7 in
the old compared with the young. The older group also has less diverse
repertoires at days 0 and 28, and they do not return to day 0 CGD values
at day 28 as the younger group do. This may be related to the slower time
to reach the peak IgA antibody response in the serum. Without the bene-
ﬁt of further time points, it is difﬁcult to judge the kinetics of the
response. It is entirely possible from these data that the IgA response in
the old follows the same pattern as the young but that it is delayed as a
whole so that it peaks later and resolves even later. Alternatively, there
may be different factors affected in the activation and resolution phases
of the response to cause these observations. Inadequate resolution of
immune responses may be just as important as a failure to respond in the
ﬁrst place, and although literature is sparse on this topic, there are indica-
tions that regulatory functions of cells may be impaired with age (Hwang
et al., 2009). A delayed resolution could be a signiﬁcant contributory fac-
tor to the observations that older people have less diverse repertoires,
because if the effects of a single challenge can still be seen a month later,
(a)
(b)
(d) (e)
(c)
Young, All lgM sequences
Old, All lgM sequences
Young, All switched (IgA & IgG) sequences
Old, All switched (IgA & IgG) sequences
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Fig. 3 Challenge results in selection of smaller, more hydrophilic, CDR3 regions. (a) Virtual spectratypes were created from sequencing data by plotting the distribution of
different sized CDR3 regions for all the IGH sequences obtained. Curves represent day 0 (circles), day 7 (triangles) and day 28 (squares). The underlying distribution, without
the clonal expansion effect, can be seen by plotting the distribution of CDR3 size when only one sequence from each clonotype is counted (Fig. S1). The mean CDR3 sizes for
all sequences are shown in (b), while the mean CDR3 sizes for unique clonotypes are shown in (c). (d) For smaller sequences, where the CDR3 size was 42bp or less, the Grand
Average Hydrophobicity values (GRAVY index) were plotted for sequences that were found only once (single) and that were found in related clones where there were more
than three sequences per clone (clonal). Only one example sequence from each clone was included to avoid bias because of clonal expansion. (e) Illustrates the difference in
average GRAVY values for single vs. clonal sequences at each different CDR3 size. At all sizes, the values for clonal sequences are lower and more hydrophilic, than those for
single sequences. Comparisons were performed by Mann–Whitney u-test. Error bars are SEM, *P < 0.01, **P < 0.001 and ***P < 0.0001.
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926then the multiple challenges we encounter as part of everyday life could
present a signiﬁcant compromise to the baseline diversity.
While we have shown that we can use spectratyping of the B-cell rep-
ertoire in an isotype-speciﬁc manner, it is clear that the high levels of
interindividual variability in prior antigen exposure are such that it would
not be useful as a predictor in a study of IgG responses. The subjects in
the study had both inﬂuenza and pneumococcal vaccinations, as part of
their normal healthcare, thus were exposed to multiple antigens simulta-
neously. In spite of the complicated challenge, there are indications that
some measures of the spectratypes can be correlated with the PPS-
speciﬁc responses. The serum IgM and IgA antibody levels at day 28 were
associated with more leptokurtotic IGHM and IGHA spectratypes at day
7. This peakedness seems to be a result of the expansion of clones
containing smaller CDR3 values. In looking for a prevaccine predictor, we
could see promising associations between the spectratype shape (CGD,
Fig. 5) and the IgM response. There was a signiﬁcant difference in CGD
values between the young and the old groups, and the individuals with
the highest levels of IgM have CGD values near to 1. If an individual is in
the over 65 age bracket and has a CGD value of lower than 0.9, then they
will not produce a high level of PPS-speciﬁc IgM antibody.
It is clear, from data here and elsewhere, that the IgM response is
severely diminished in the older population. Whether this is because of a
failure of the TD or the TI pathway of B-cell activation cannot be deter-
mined from these data, but the nature of the PPV23 vaccine would lead
one to expect the latter. In the light of these data, and the recent report
that removal of IgM antibody from serum diminishes opsonophagocytic
activity against two common PPS serotypes (Park & Nahm, 2011), it
would seem appropriate that future studies aimed at improving PPS
responses in the elderly should include consideration of the IgM response.
In addition, we found that although the IgA serum response was not sig-
niﬁcantly different in the two age groups at day 28, there was a signiﬁ-
cant difference at day 7 (Fig. 4). This implies that there might be an
age-related temporal difference in either production or trafﬁcking of IgA.
Temporal differences such as this in the face of bacterial infection could
have severe consequences for an individual, and these data have high-
lighted the need for analysis at different time points after vaccination.
Although we saw a signiﬁcant increase in IgG ANA autoantibodies with
age, we did not see any evidence that vaccination caused an increase as
has previously been reported (Huang et al., 1992). This may be due to dif-
ferences in adjuvant use in vaccines, but it is comforting to know that the
recent commonly used vaccines have no deleterious effects in this
respect.
Perhaps the most striking observation from these spectratype data is
that the mean size of the CDR3 region is signiﬁcantly decreased after
(a) (b)
(d) (e)
(c)
Fig. 4 Antibody responses to vaccination. ELISA was performed using a pool of seven pneumococcal polysaccharides (4, 6B, 9, 14, 18C, 19F and 23F) and speciﬁc for (a) IgG,
(b) IgA or (c) IgM antibodies. The levels of IgG antinuclear antibody were also determined at each time point (d), and we found a signiﬁcant correlation between the mean
CDR3 size of the IGHM spectratype at day 0 and the levels of IGANA at day 0 (e). Comparisons were performed by Mann–Whitney u-test. Correlation by Pearson’s test. Error
bars are SEM, *P < 0.01, **P < 0.001 and ***P < 0.0001.
Fig. 5 IGHM spectratype before vaccination has some predictive ability. The
increase in IgM pneumococcal polysaccharide-speciﬁc antibody at day 28 shows a
signiﬁcant correlation with the CGD index of the IGHM spectratype. Samples in the
young group are plotted as open circles, those in the old group as solid triangles.
Correlation by Pearson’s test.
Vaccine-induced changes in B-cell repertoire, A. Ademokun et al.
ª 2011 The Authors
Aging Cell ª 2011 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland
927challenge in both young and old age groups for all isotypes. The extent of
the change in the CDR3 size appears to be the same for both age groups,
but the old group starts at a higher size in the ﬁrst instance, so that there
are signiﬁcant age-related differences in CDR3 size both before and after
vaccination (Fig. 1e). The precise effect of these differences is not known,
because we could not ﬁnd any clear correlations between CDR3 size and
serum antibody. The lack of correlations with antibody might reﬂect the
noise in the experiment caused by having multiple vaccine challenges at
the same time, or it may be due to some other factor such as differential
locations for responding cells vs. responding antibody. The sequencing
data conﬁrm the spectratype data, showing an overall decrease in mean
CDR3 size, and also show that when the effect of clonal expansion is
removed the challenge-induced CDR3 size shift is similar between the
two groups. Selection for smaller CDR3 size has previously been reported
in the germinal centre response to hapten NP in mice (Lacroix-Desmazes
et al., 1998), and a study of 256 peripheral blood IGHV6-1 IgM genes in
humans has noted that antigen-experienced genes have shorter CDR3
than those that are unmutated (Rosner et al., 2001). More recently, we
have shown for the whole repertoire of IGHV genes in three young indi-
viduals that memory B cells have shorter CDR3 regions than naı ¨ve or tran-
sitional B cells (Wu et al., 2010). This is also apparent in these data,
where class-switched (and therefore antigen-experienced) genes have
shorter CDR3 regions than IgM genes even at day 0. A small CDR3 size
appears to be important in relation to the hydrophobic nature of the anti-
gen-binding site of the antibody; lower sizes of CDR3 regions tend to
have a lower hydrophobicity and within this, even when sequences of the
same size are compared, those that belong to expanded clones have a
further decrease in hydrophobicity compared with the unique sequences.
So it looks very much as if sequences with a smaller, more hydrophilic,
antigen-binding site are being selected and expanded in the younger
population more so than in the old.
In summary, even though the level of serum IgA and IgM antibodies is
much lower than that of IgG antibodies, it is in the two former isotypes
that the signiﬁcant age-related defects in the response to pneumococcal
vaccine are found. B-cell spectratype analysis of IGHM sequences seems
to be the most promising avenue for predicting responses to pneumococ-
cal vaccination, although it appears that there are still factors other than
B-cell repertoire that are involved in the senescence of the humoral
immune response. We have also shown clear evidence that expansion of
IGH sequences that have smaller, more hydrophilic, CDR3 regions is a fea-
ture of these common vaccinations and that the clonal expansion is
reduced in the older group. Given the apparent importance of the CDR3
region in this respect, it is of note that the baseline repertoire of older
people comprises larger CDR3 regions, on average, than the younger
group and therefore may be at a disadvantage in the initiation of appro-
priate immune responses.
Experimental procedures
Volunteers and sample collection
Young (age 18–49, n = 39) and older (age 65-89, n = 27) volunteers
were recruited during the 2009⁄10 and 2010⁄11 inﬂuenza vaccination
seasons from Lambeth Walk GP Practice and King’s College London with
informed consent and approval from the Guy’s Hospital Research ethics
committee. Blood and serum samples were collected prior to vaccination
with the inﬂuenza (Inﬂuvac; Solvay, Southampton, UK) and 23-valent
pneumococcal (Pneumovax II; Sanoﬁ Pasteur MSD, Maidenhead, UK) vac-
cines and at 7 and 28 days postvaccination. PBMCs were isolated using
Ficoll-Paque Plus (GE Healthcare, Buckinghamshire, UK) and Leucosep
tubes (Greiner Bio-One Ltd.,Gloucestershire, UK) counted and stored in
freezing medium till required. Preparation and freezing in this manner
have been shown not to affect the survival of day 7 postvaccine plasma-
blasts (Kyu et al., 2009). Samples from a subset of six young (aged 19–
45, average 27 years) and six old (aged 70–89, average 78 years) subjects
were chosen for IGH CDR3 sequencing.
Nucleic acid extraction and cDNA conversion
Frozen PBMCs were thawed before nucleic acid extraction using the
AllPrep DNA⁄RNA extraction kit (Qiagen, Crawley, UK). cDNA was gener-
ated from RNA using the reverse transcription system (Promega, South-
ampton, UK) according to manufacturer’s protocol.
Spectratypes
The CDR3 region of the rearranged IGH gene was ampliﬁed from cDNA
using a PCR with Fw3Fam (ACACGGCTGTGTATTACTGT with a 5¢-cou-
pled Fam) and isotype-speciﬁc Ca,C c or Cl primers (Ca = GGAA-
GAAGCCCTGGACCAGGC; Cc = CACCGTCACCGGTTCGG and Cl =
CAGGAGACGAGGGGGAA). A 25-lL reaction mix contained 0.2 U Phu-
sion DNA polymerase (NEB, Hitchin, UK), 200 lM of each dNTP and
0.4 lM of each primer (Fw3Fam plus one of the three isotype-speciﬁc
primers) in 1· reaction buffer containing 1.5 mM MgCl2. PCR was ampli-
ﬁed in 25 cycles of 98 C (30 s), 55 C (30 s) and 72 C (30 s), and 1 cycle
of 72 C (5 min). Annealing temperature for Ca was 61 C.
Polymerase chain reaction samples (3 uL) were added to 1.5 uL Tamra
350 standard in formamide and run on the ABI 3730xl capillary sequen-
cer. Data were analysed using Genescan (Applied Biosystems, Carlsbad,
CA, USA) for fragment size analysis exported to Excel. These values were
copied into Microsoft Excel ﬁles which were imported and analysed fur-
ther in the R statistical programming environment (R Development Core
Team, 2011). Raw peak data were normalised, so that the sum of all the
peak heights for a sample was set to 100. A sample (n = 3000) was then
generated from this relative frequency distribution and the mean, SD,
skew and kurtosis calculated. To generate a reference Gaussian distribu-
tion, day 0 and 28 samples were combined (except for three instances
where one sample showed a very low raw signal), and the mean and SD
of this joint sample were used to deﬁne a normal distribution for each
patient⁄isotype combination. The Pearson’s correlation coefﬁcient for
each sample compared with the respective Gaussian distribution was
then recorded as correlation to Gaussian distribution (CGD).
Detection of antipneumococcal polysaccharide antibodies
Brieﬂy, 96-well plates were coated overnight at 4 C with 100 lL per well
of a combination of seven polysaccharide serotypes (4, 6B, 9, 14, 18C,
19F and 23F, 1 lgm L
)1 each; ATCC, Rockville, MD, USA) in PBS with
0.02% NaN3. After coating, plates were washed three times with wash
buffer (TBS containing 0.1% Brij 35; Sigma-Aldrich, St. Louis, MO, USA)
using an automated plate washer. All serum samples were pre-absorbed
with 10 lgm L
)1 of cell wall polysaccharide (CPS; Statens Serum Institut,
Copenhagen, Denmark) and 10 lgm L
)1 of 22F polysaccharide in anti-
body buffer (PBS with 0.05% Tween-20) for 30 min at room temperature
(RT). The reference serum standard, 89-SF, from the Food and Drug
Administration (Bethesda, MD, USA), was absorbed with 10 lgm L
)1
CPS only. The pre-absorbed serum samples and 89-SF were serially
diluted and added to the microtiter plates. Plates were incubated over-
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928night at 4 C then washed as described earlier. Alkaline phosphatase-con-
jugated goat anti-human IgG (Invitrogen, Paisley, UK) at a 1⁄10000 dilu-
tion in antibody buffer was added to the plates and incubated for 2 h at
RT, and the plates were then loaded with p-nitrophenyl phosphate sub-
strate (Sigma-Aldrich) in diethanolamine buffer and incubated for 2 h at
RT. Reactions were stopped by the addition of 3 M NaOH, and the optical
density at 405 nm was measured with a 630-nm reference using an ELISA
microplate reader. The amount of antibody was determined by compari-
son with the 89-SF standard.
IgA and IgM plates were with HRP-conjugated goat anti-human IgA
(Invitrogen) or IgM antibodies (Thermo Fisher, Huntsville, AL, USA) at
1⁄4000 in antibody buffer for 2 h at RT. Plates were detected with TMB
chromogen substrate (Invitrogen), and OD was read at 450 nm.
Statistics
Statistics were performed with GraphPad Prism 4.0 (Graphpad Inc, La
Jolla, CA, USA) using Mann–Whitney u-test to compare groups, chi-
squared to compare frequencies and Pearson’s correlation analysis to test
for association between different metrics.
IgG ANA
Nonorgan-speciﬁc autoantibodies (ANA) were screened by indirect
immunoﬂuorescence on HEp-2 cells. By using the fully automated read-
ing system AKLIDES (Hiemann et al., 2009) for screening and preclassiﬁ-
cation of ANA, we could minimise variation of detected intensities.
Sequencing
High-throughput sequencing of IGHV genes was performed as previ-
ously described (Wu et al., 2010). Brieﬂy, IGHV genes were ampliﬁed
using a seminested, isotype-speciﬁc PCR, with primers containing
multiplex identiﬁer (MID) sequences in the second round of ampliﬁca-
tion. To produce sufﬁcient DNA for sequencing, while minimising
PCR ampliﬁcation, PCR repeats were performed for each individual
experimental sample. PCR primers were removed from the pooled
products by electrophoresis and using QIAquick gel puriﬁcation kit.
Samples to be pooled for sequencing were mixed in equal quantities
and concentrated using QIAquick PCR puriﬁcation kit (Qiagen) before
sequencing on the GS FLX Titanium sequencer (Agowa GmBH, Berlin,
Germany). Accuracy of the method as a whole was previously deter-
mined to be less than one error per 1300 bp (not counting indels).
After sequencing, the sequences were subjected to stringent quality
controls and assigned to the corresponding samples based on the ter-
minal MID sequence. The amino acid sequence of each CDR3 junc-
tion region was determined using V-Quest, allowing for indels. The
physicochemical properties of the peptide between the conserved ﬁrst
and last amino acid positions were determined using ProtParam.
Clonally related sequences were identiﬁed based on the DNA
sequence of the CDR3 (‘junction’) region as reported by V-Quest. A
distance matrix between all pairwise comparisons was created as fol-
lows. For each sequence pair, the shorter sequence was deﬁned as
the test sequence. If the other sequence was 10 or more nt longer,
or belonged to a different IGHV gene family, the distance was set at
1 (unrelated). Otherwise, the distance between the sequences was
deﬁned as minimum edit distance normalised to the length of the
test sequence, upto a maximum of 1 in 5 (or a total of 10) mis-
matches or indels. This distance matrix was then used for hierarchical
clustering (complete method), with clones being deﬁned by cutting
the resultant dendrogram at a distance of 0.25.
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mococcal vaccine levels.
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